Results 21 to 30 of about 3,803 (163)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis

open access: yes, 2022
Aim: To review and compare the PON-1 arylesterase activity between coronary artery disease (CAD) and non-CAD patients. Methods: Data were obtained by searching MEDLINE and Scopus for all investigations published between January 1, 2000 and March 1, 2021 ...
Zuin M.   +9 more
core   +1 more source

Correlation between paraoxonase-1 arylesterase activities and clopidogrel drug in patients with coronary artery disease [PDF]

open access: yes, 2022
Background: Coronary artery disease (CAD) is one of the leading causes of death worldwide. Clopidogrel, antiplatelet drug, has been widely used for management of CAD.
Numan, Ali Waleed, Khudair, Likaa Kareem
core   +1 more source

Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury

open access: yesEurasian Journal of Medicine, 2019
Objective: This study investigated changes in serum oxidative stress parameters in burn cases compared to healthy controls. Materials and Methods: This study was performed in 41 burn patients with mild to severe thermal burn injuries and 38 healthy ...
Serap Yildirim   +5 more
doaj   +1 more source

Oxidative stress and peri-implantitis: The role of oxidants and antioxidants [PDF]

open access: yesJournal of Oral Health and Oral Epidemiology, 2023
Background: Peri-implantitis is the main cause of implant failure and is associated with augmented oxidative stress or tissue destruction. In this study, it was aimed to investigate the oxidant-antioxidant balance parameters in individuals with peri ...
Gülbahar Ustaoğlu   +2 more
doaj   +1 more source

Distribution of Paraoxonase 1 polymorphisms and activities in obese patients

open access: yesRomanian Journal of Laboratory Medicine, 2013
Obiectivul studiului a fost de investigarea fenotipului şi genotipului PON1 la pacienţii români cu obezitate abdominală. Material şi metodă. Loturile din studiu au constat din 88 de pacienţi cu obezitate abdominală şi 46 subiecţi cu circumferinţă ...
Ciumărnean Lorena   +6 more
doaj   +1 more source

Paraoxonase 1 Activity and its Polymorphism in Type 2 Diabetic Nephropathy

open access: yesEndocrinology Research and Practice, 2018
Objective: This study aims to investigate the role of paraoxonase 1 activity and Q192R polymorphism in the development of nephropathy in patients with Type 2 diabetes mellitus.
Mukund R. MOGAREKAR   +2 more
doaj   +1 more source

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene

open access: yesGenetics and Molecular Biology, 2018
Paraoxonase 1 (PON1) is a serum enzyme associated with high density lipoprotein (HDL) regulation through its paraoxonase and arylesterase activity. PON1 inhibits the oxidation of HDL and low density lipoprotein (LDL), and is involved in the pathogenesis ...
Muhammad Idrees   +7 more
doaj   +1 more source

Arylesterase activity in trace element contaminated soils

open access: yes, 2011
Arylesterase activity was measured along with microbial biomass C (BC) and respiration, and H2O-soluble and NH4NO3-exchangeable trace elements (TE), in contaminated soils (TECS) from three long-term field trials.
Mench M.   +14 more
core   +1 more source

Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum

open access: yes, 2014
Context: Cholinesterase (ChE) specific activity is the ratio of ChE activity to ChE mass and, as a biomarker of exposure to cholinesterase inhibitors, has a potential advantage over simple ChE activity.
Paul Strickland   +2 more
core   +1 more source

Study of Oxidative Stress Marker Serum Paraoxonase in Metabolic Syndrome

open access: yesEndocrinology Research and Practice, 2016
Purpose: The metabolic syndrome (MetS) is a constellation of interrelated risk factors of metabolic origin that appear to promote development of cardiovascular disease.
Mohit Rojekar   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy